GSA Capital Partners’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-449
Closed -$62K 2044
2023
Q2
$62K Sell
449
-2,781
-86% -$357K 0.01% 1412
2023
Q1
$294K Buy
3,230
+2,995
+1,274% +$407K 0.03% 1040
2022
Q4
$32K Buy
235
+93
+65% +$31.5K ﹤0.01% 1380
2022
Q3
$123K Sell
142
-1,759
-93% -$1.1M 0.02% 1333
2022
Q2
$833K Buy
1,901
+92
+5% +$48K 0.13% 209
2022
Q1
$1.15M Buy
1,809
+1,680
+1,302% +$1.06M 0.15% 133
2021
Q4
$115K Buy
129
+23
+22% +$24.2K 0.01% 1305
2021
Q3
$135K Buy
+106
New +$128K 0.01% 1294

Other funds holding CANO

GSA Capital Partners's CANO Position: Q3 2023 in Review

GSA Capital Partners sold out of Cano Health, Inc. (CANO) in Q3 2023, closing a stake of 449 shares — an estimated $62K sold.

GSA Capital Partners first reported a position in CANO in Q3 2021 and held it in 8 quarters. The position peaked at $1.15M in Q1 2022. 134 funds tracked by Wall St. Rank hold CANO as of Q3 2023.

  • GSA Capital Partners reported no remaining Cano Health, Inc. position as of Q3 2023 after selling out during the quarter.
  • GSA Capital Partners sold 449 Cano Health, Inc. shares in Q3 2023, an estimated $62K.
  • GSA Capital Partners first reported a position in Cano Health, Inc. in Q3 2021 and held it in 8 quarters.
  • GSA Capital Partners's Cano Health, Inc. position peaked at $1.15M in Q1 2022.
  • 134 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2023.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.